SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-24-008391
Filing Date
2024-05-17
Accepted
2024-05-17 07:05:13
Documents
15
Period of Report
2024-05-17
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K mrns-20240517x8k.htm   iXBRL 8-K 44378
2 EX-99.1 mrns-20240517xex99d1.htm EX-99.1 28499
3 GRAPHIC mrns-20240517xex99d1001.jpg GRAPHIC 6690
  Complete submission text file 0001558370-24-008391.txt   213299

Data Files

Seq Description Document Type Size
4 EX-101.SCH mrns-20240517.xsd EX-101.SCH 3117
5 EX-101.LAB mrns-20240517_lab.xml EX-101.LAB 16590
6 EX-101.PRE mrns-20240517_pre.xml EX-101.PRE 10712
18 EXTRACTED XBRL INSTANCE DOCUMENT mrns-20240517x8k_htm.xml XML 5063
Mailing Address 5 RADNOR CORPORATE CENTER SUITE 500 100 MATSONFORD RD RADNOR PA 19087
Business Address 5 RADNOR CORPORATE CENTER SUITE 500 100 MATSONFORD RD RADNOR PA 19087 484-801-4670
MARINUS PHARMACEUTICALS, INC. (Filer) CIK: 0001267813 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36576 | Film No.: 24957684
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)